Is Trade Capital Markets (TCM) Ltd a Scam?

At FXCanary, our safety verdict is never a simple binary; it is the product of layered research that traces the corporate structure back to the regulator, scours public registries, and weighs the quality of client-protection mechanisms. For Trade Capital Markets (TCM) Ltd, we started with the bare record: a Cyprus Investment Firm authorised by the Cyprus Securities and Exchange Commission (CySEC) under licence number 227/14. That licence is the primary pillar of our safety analysis, but it’s only the beginning.

Our proprietary Scam Risk Score aggregates dozens of signals — from regulatory status and ownership transparency to the track record of client fund handling. A score of 34/100 places TCM in the ‘Guarded’ band, which means the broker possesses a genuine regulatory backbone, yet the overall picture contains enough gaps and complexities to warrant caution rather than wholesale reassurance. In the sections that follow, we unpack precisely what went into that score and how a trader can calibrate their own risk tolerance.

A score of 34/100 is neither a red flag nor a green light; it reflects a broker with a solid regulatory anchor but limited independent corroboration. The primary driver of the relatively low risk is the live CySEC licence, which we verified against the CySEC public register. A firm that holds a CIF licence has passed significant fitness-and-propriety tests, must submit regular prudential returns, and is subject to ongoing supervision.

The score remains in the guarded tier because, in our independent checks, we found no substantial body of third-party user reviews or long-form audit reports that would allow us to corroborate trading conditions or dispute-resolution outcomes. In other words, the regulatory box is ticked, but the real-world trading experience is not yet well-documented by independent parties. For traders who rely heavily on community feedback, this information vacuum should be noted.

Additionally, the broker’s online footprint includes multiple brands and domains, which is not unusual but can create confusion about which entity is ultimately responsible for holding your funds. As we will discuss, clarity around brand hierarchy is essential for assessing safety, and the complexity here nudged the score upward.

Trade Capital Markets (TCM) Ltd is regulated by CySEC as a Cyprus Investment Firm (CIF). CySEC is an EU national competent authority, meaning that TCM must comply with the Markets in Financial Instruments Directive (MiFID II) and the Capital Requirements Regulation. In practice, this forces the broker to maintain adequate capital buffers, submit to external audits, and adhere to strict conduct-of-business rules.

We confirmed the licence number 227/14 on the CySEC website, and the status appears as ‘Authorised’. This is not a lapsed registration or an offshore clone; it is a fully operational licence. For a retail trader, this means access to the EU’s harmonised investor-protection framework, which we detail below.

Crucially, CySEC-regulated firms are also required to participate in the Investor Compensation Fund (ICF). If TCM were to become insolvent and fail to return client assets, the ICF can compensate eligible retail clients up to €20,000 per claim. This is a meaningful safety net, though it is not catastrophic-loss insurance, and the payout process can take months.

MiFID II obliges TCM to keep retail client money in segregated accounts with EU credit institutions, separate from the firm’s own working capital. This segregation is designed to ensure that in the event of the broker’s insolvency, client funds are not treated as company assets and can be returned to clients before creditors are paid. TCM’s own disclosures affirm that they adhere to this standard.

Negative balance protection is another mandatory safeguard for retail clients under CySEC rules, meaning a trader cannot lose more than the total deposited. While leveraged CFDs are inherently high-risk, this provision puts a floor under potential losses. The broker also prominently displays a 72% loss-rate warning on its website, which is a regulatory requirement and a sober reminder of the product’s volatility.

We compared TCM’s compensation framework to other EU brokers and found it to be standard: segregation, negative balance protection, and ICF coverage. There is, however, no evidence of additional private insurance or enhanced protection above the statutory minimum. Traders with balances exceeding €20,000 should be aware that only that threshold is guaranteed by the statutory safety net.

A CySEC licence allows a CIF to ‘passport’ its services into other European Economic Area (EEA) member states via a simple notification procedure. TCM’s own website lists multiple jurisdictions where it has cross-border registrations, including Austria, Bulgaria, Croatia, and others. We went through the company’s published passport links and verified that the registrations appear in the corresponding national registers, though some download links lead to large PDF files requiring manual search.

This passporting feature means a trader in, say, Vienna or Sofia is dealing with a broker that is still overseen by CySEC, but the host-state regulator also has supervisory powers for conduct issues. In our assessment, this dual-oversight model is a positive safety feature, as it creates multiple avenues for complaint and enforcement.

However, we note that the broker’s passport page is a little rough around the edges — some links are missing or lead to generic regulator homepages rather than direct entries. This doesn’t invalidate the registrations, but it does add a small layer of friction for a trader attempting to independently verify the licence in their home country. A security-conscious trader should always cross-check the passport directly with the host regulator’s online database.

One of the more complex aspects of TCM’s safety profile is its multi-brand operation. The broker’s own regulation page lists Trade.com and Heromarkets.com as associated brands, and the corporate disclosure reports show related entities like Trade Capital Holding. In practice, a trader searching for ‘Trade Capital Markets’ might end up reading about ‘Trade.com’ instead, and not immediately realise that they are the same underlying company.

From a safety standpoint, multiple brands are not inherently fraudulent; many large brokers operate distinct trading names for different markets. The risk arises when the entity where your money ends up is unclear. We searched for independent reviews of TCM specifically, and almost all public commentary we found referred to the Trade.com brand rather than the Trade Capital Markets name. That makes it more difficult to isolate TCM-specific service issues.

Our advice: before opening an account, verify that the legal entity shown in the client agreement is Trade Capital Markets (TCM) Ltd, with CySEC licence 227/14. If the documentation mentions a different company — perhaps a Mauritius-registered entity under the same brand — the client-protection framework will be entirely different. The search results did contain references to a Mauritius-licensed affiliate, and while that does not involve TCM Ltd itself, a hurried trader could accidentally onboard with the weakly regulated entity.

TCM publishes annual Market Discipline Reports on its website, and we reviewed the FY2024 and FY2022 editions. These documents outline the firm’s risk-management policies, governance structure, and capital adequacy ratios. They are a public demonstration of the transparency expected of a MiFID firm and, in themselves, are a reassuring signal: fly-by-night operations rarely produce such formal disclosures.

The FY2024 report confirms that TCM maintains a Board of Directors, follows a diversity policy, and operates a risk management framework. However, detailed financial figures — such as the actual capital ratio or the precise volume of client assets — are either redacted or omitted on proprietary grounds. While this is allowed under the regulation, it limits a trader’s ability to independently gauge the firm’s financial health.

We also noted a separate disclosure report for Trade Capital Holding (TCH) Ltd, suggesting a holding company structure. Without a full group chart, it’s hard to see how intercompany dependencies might affect the operating broker. For the cautious trader, this is another element of opacity in an otherwise regulated setup.

Given the incomplete independent picture, traders should take a few extra precautions. First, open the account directly through the tradecapitalmarkets.com domain and double-check that the client agreement names TCM Ltd as the counterparty. Avoid signing up through affiliate sites that may re-route you to a different legal entity.

Second, test the support channels early. A broker that is slow to respond to a pre-sales query about regulation or fund safety may not be responsive when a real problem occurs. Ask them to confirm where your money will be held and request a bank letter if possible.

Finally, keep your initial deposit modest until you have withdrawn profits at least once. While CySEC oversight provides a robust framework, the lack of a established user track record means the real-world experience — execution quality, withdrawal processing — is still an unknown quantity for this specific entity.

Trade Capital Markets (TCM) Ltd is a legitimate CySEC-regulated broker that offers the statutory protections EU traders now consider table stakes: segregated accounts, negative balance protection, and ICF coverage up to €20,000. Its licence is genuine, its online disclosures are substantial, and it has a physical presence in Cyprus.

The ‘Guarded’ Scam Risk Score of 34/100 is a balanced reflection of the fact that, while the regulatory framework is strong, there is insufficient independent evidence — no verified user reviews, no publicly available audit details — to elevate the broker to a higher confidence tier. The multi-brand structure also demands that a trader remain alert to exactly which legal entity they are dealing with.

For a retail trader who is comfortable operating within the EU regulatory perimeter and willing to do their own due diligence, TCM is not a scam. But the absence of a broad user footprint means safety is currently more a matter of regulatory design than of demonstrated market conduct. We will update our assessment as new information emerges.